Market Definition
Industrial Microbiology refers to the use of microorganisms in multiple ways for developing any product in an industry. Mutations are one of the processes in which the DNA sequence is changed to get the desired result. Plasmids & vectors are used for gene amplification of the microorganism to get the maximum production.
In pharmaceutical industries, industrial microbiology products are used for manufacturing drugs, vaccines, & medicines. On the other hand, in the food & beverages industries, they are used for food fermentation. Apart from this, in laboratories, they can be used for manufacturing cosmetics & chemicals and in the agriculture sector, for preparing fertilizers & pesticides.
Market Insights
The Global Industrial Microbiology Market is projected to grow at a CAGR of around 6.8% during the forecast period, i.e., 2022-27. The growth of the market is driven primarily due to increasing demand in the pharmaceutical sector to develop drugs & vaccines. Pharmaceutical industries have been expanding their R&D and production to meet the growing demand of consumers. For instance:
| Report Coverage | Details |
|---|---|
| Study Period | Historical Data: 2017-20 |
| Base Year: 2021 | |
| Forecast Period: 2022-27 | |
| CAGR (2022-2027) | 6.8% |
| Regions Covered | North America: USA, Canada, Mexico |
| Europe: Germany, UK, France, Italy, Spain, Russia | |
| Asia-Pacific: China, India, Japan, South East Asia, Australia | |
| South America: Brazil, and Argentina | |
| Middle East & Africa: UAE, Saudi Arabia, South Africa, Nigeria, Turkey, Egypt | |
| Key Companies Profiled | Thermo Fisher Scientific Inc., SSI Diagnostica, Sartorius AG, Novamed Ltd., Eppendorf AG, Becton Dickinson & Company, Bio-Rad Laboratories Inc., Sigma Aldrich, Biomerieux Industry, 3M, Asiagel Corporation, Others |
| Unit Denominations | USD Million/Billion |
In addition, the use of industrial microbiology is also expected to grow due to the growing inclination of users toward cosmetic products. Microorganisms produce a variety of low-molecular-weight chemical compounds, including alcohols, proteins, polysaccharides, and several organic acids, in optimum conditions, which can be used for various applications in cosmetics industries. These compounds act as active ingredients for the protection against Ultra Violet (UV) radiation, anti-aging or antibacterial agents, or as binding, thickening, coloring, & stabilizing agents.
Key Trend in the Global Industrial Microbiology Market
RMT rapidly maximizes the potential of QC lab with microbial detection & enumeration at any scale and offers enhanced accuracy & data integrity. It can provide automated & non-destructive detection. Rapid Microbiology delivers results in just 18–24 hours for bioburden & microbial limits and approximately 6 days for sterility testing results. , i.e., less than half the time required by traditional methods. This method decreases the working capital requirements and the lab waste, thereby improving sustainability.
In industrial microbiology, these rapid methods are highly capable of delivering real-time results. ATP-bioluminescence is one such method for assessing contamination levels in pharmaceutical products and raw materials. It utilizes a specific substrate and an enzyme combination, luciferase, to break down microbial ATP from growing cells and produce visible light. For instance:
Impact of Covid-19 on the Global Industrial Microbiology Market
In 2020, the Covid-19 pandemic severely impacted the Global Industrial Microbiology Market by hampering the production of equipment & consumables utilized in industrial microbiology processes. It is because most companies involved in the healthcare sector were focused mainly on the development & approval of testing kits, rapid detection assays, and drugs & vaccines to reduce the impact of coronavirus.
As a result, the academic & industry?based laboratories investigating new industrial microbiology products & gene therapies got shut down or were compelled to reduce their activities. Due to project delays or cancellations and the inevitable increase in costs, funding agencies were struggling to manage the situation.
However, there were new activities like remote video conferencing to keep going with the exchange of results & ideas in industrial microbiology research during the pandemic. Currently, governments worldwide are seeking various avenues to enhance the quality of treatment and provide patients suffering from rare diseases with easy access to these treatments. Companies like Thermo Fisher, BioRad, and HiMedia have increased their production capacity in manufacturing assays, kits, and other lab consumables for their utilization in research
.png)